What is the best-rated treatment for hypereosinophilic syndrome?

By our independent recall-safety rating — not an efficacy measure — gleevec ranks highest among the products we list for hypereosinophilic syndrome. Always consult a professional.

How are these treatments ranked?

By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.

What types of drugs treat hypereosinophilic syndrome?

Treatments for hypereosinophilic syndrome span FDA drug classes including kinase inhibitor. Compare every option side by side, ranked by independent rating, above.

Best treatments for hypereosinophilic syndrome

2 products may treat hypereosinophilic syndrome, spanning FDA drug classes such as kinase inhibitor. The current highest-rated option is gleevec. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 2 drugs we list for hypereosinophilic syndrome, all are available as lower-cost generics, spanning classes such as kinase inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for hypereosinophilic syndrome — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Treatments we list for hypereosinophilic syndrome
#	Drug	Rating	Type	Form	Class	Generic?	Pharmacy pays
1	Gleevec	70/100	Prescription	Tablet	Kinase Inhibitor	Generic	$26	View →
2	Imkeldi	Not yet rated	Prescription	Solution	Kinase Inhibitor	Generic	$26	View →

Narrow by drug class

Best kinase inhibitor for hypereosinophilic syndrome (2)

Explore the class hubs: kinase inhibitor

Full ranking · 2 treatments

#3 of 20 in Kinase Inhibitor

gleevec

PrescriptionFDA-sourced

70/100

Gleevec (Imatinib Mesylate) is a kinase inhibitor used to treat Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome, Dermatofibrosarcoma.

(13 data points)

kinase inhibitorleukemia, lymphoidleukemia, myeloid

Pharmacy pays

From ~$23.82/30· 2 forms

View details →

imkeldi

PrescriptionFDA-sourced

New

Imkeldi (Imatinib Mesylate) is a kinase inhibitor used to treat Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome, Dermatofibrosarcoma.

kinase inhibitorleukemia, lymphoidleukemia, myeloid

Pharmacy pays

From ~$23.82/30· 2 forms

View details →

Frequently asked

What treats hypereosinophilic syndrome?: Our catalog lists 2 products that may treat hypereosinophilic syndrome, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is gleevec.
What is the best-rated treatment for hypereosinophilic syndrome?: By our independent recall-safety rating — not an efficacy measure — gleevec ranks highest among the products we list for hypereosinophilic syndrome. Always consult a professional.
How are these treatments ranked?: By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat hypereosinophilic syndrome?: Treatments for hypereosinophilic syndrome span FDA drug classes including kinase inhibitor. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.